Many medical researches are at the intersection of bioengineering, chemistry and medicine and have the potential to create a significant transformation in the health sector.
In our Nanotechnology and Biomaterials Laboratory and Biotechnology Laboratory, innovative approaches are being developed for the simultaneous diagnosis and treatment of diseases by utilising the properties of nanomaterials. Assoc. Prof. Dr. Ali Zarrabi, one of the faculty members of Biomedical Engineering at the Faculty of Engineering and Natural Sciences, aims to contribute to the early diagnosis of common diseases such as cancer, diabetes and cardiovascular diseases and to find fast and effective treatment methods with his studies in this field.
The researches are planned to develop low-cost, unique and effective biomaterials. These biomaterials are being developed to make a difference in clinical applications, to recognise and treat diseases at earlier stages. In particular, studies on biosensors and bedside testing systems aim to diagnose diseases faster and initiate treatment processes more rapidly.
While giving information about his studies, Assoc. Prof. Dr. Ali Zarrabi said; "Our studies on smart drug systems and targeted treatment methods continue. These systems increase the effectiveness of treatment by directing drugs directly to the diseased area and focus on reducing side effects. Functional biomaterials produced for tissue engineering applications are also being designed. These studies, which will improve the quality of healthcare services, are progressing with the aim of reaching more people at an affordable cost."
The researches will not only improve existing treatment methods, but also offer solutions to important problems in the health sector.